Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Ajanta Pharma Limited, a Rs.1,450 crore plus Mumbai based specialty focused pharmaceutical formulation company, has received final approval from the United States Food and Drug Administration (FDA)  for its 3 Abbreviated New Drug Applications (ANDAs), montelukast tablets, 10mg,  montelukast sodium chewable tablets, 4mg & 5mg and montelukast oral granules.

  • Pharma Major Lupin Limited (Lupin) today announced the opening of its new Center of Excellence for Inhalation Research in Coral Springs, Florida. Local and state leaders, including Florida Lieutenant Governor Carlos Lopez-Cantera, Florida Department of Economic Opportunity Director Jesse Panuccio, and Mayor Skip Campbell, were on site to celebrate the opening of Lupin’s new facility with a ribbon cutting ceremony.

  • · Marked rescue effect of the drug UDCA on cell batteries (mitochondria) in Parkinson’s disease patient tissue
    · First study to demonstrate beneficial effects of UDCA on the nerve cells affected in Parkinson’s disease in a genetic animal model of Parkinson’s disease
    · UDCA is already approved for use in human liver disease
    · Results of the study support fast track of UDCA to clinical trials and could save years of research and hundreds of millions of pounds.

  • A study conducted at Arizona State University says that bees naturally immunize their offspring against specific diseases. The scientists found that a bee blood protein called vitellogenin plays a critical, but previously unknown role in providing bee babies protection against disease.

  • Until now genetic aberrations have been seen as the main cause of almost all cancers.  A new study says ovarian cancer cannot can solely occur as a result of protein imbalances within the cells.  The study was published in the journal Oncogene.

  • ANI Pharmaceuticals, Inc., an integrated specialty pharmaceutical company, announced that its ANDA collaboration partner Sofgen,  received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nimodipine 30mg capsules. ANI and Sofgen expect to begin shipping to customers this year.

Subscribe to Pharma News